1) HCV core antigen(HCV-cAg)
HCV核心抗原(HCV-cAg)
2) HCV core antigen
HCV核心抗原
1.
Methods The serum HCV core antigen, which was taken from 149 patients with chronic hepatitis C, 20 patients of chronic hepatitis B and 20 health volunteers, was detected by ELISA.
目的:应用酶联免疫吸附试验(enzymelinkedimmunosorbentassay,ELISA)定性检测血清中丙型肝炎病毒(hepatitisCvirus,HCV)核心抗原,分析和评价HCV核心抗原检测的临床价值。
2.
OBJECTIVE To investigate the p re valence of HCV core antigen in blood donors with negative HCV antibody and evalu ate the residual risk of posttransfusion infection HCV after HCV antibody detect ion.
目的观察丙型肝炎病毒(HCV)抗体阴性献血人群HCV核心抗原的流行情况,初步评估经HCV抗体检测后输血传播HCV的潜在风险。
3.
Objective: To discuss the efficacy of HCV core antigen enzyme-linked immunosorbent assay on routine blood screening.
方法 :采用美国强生 (ORTHO)公司HCV核心抗原酶联免疫 (ELISA)检测试剂 ,对无偿献血者样进行检测 ,并对结果进行分析 ,阳性者用荧光定量PCR方法进行HCV检测 ,并将抗体检测、抗原检测、病毒核酸检测 (nucleicacidtesting ,NAT)的检测结果进行比较。
3) hepatitis C virus core protein
HCV核心蛋白
1.
Screening of proteins interacting with hepatitis C virus core protein from T7-phage display library;
用T7噬菌体展示技术筛选HCV核心蛋白的相互作用蛋白
4) HCV core protein
HCV核心蛋白
1.
Objective:To investigate expression of HCV core, mutant p53,Mdm2,p14 ARF p21 WAF1/CIP1proteins and correlation of these proteins in the HCC tissues ; to explore weather HCV core protein affects expression of mutant p53,Mdm2, p14 ARF p21 WAF1/CIP1proteins and their clinic significance.
目的:研究原发性肝癌(HCC)组织中核心蛋白、突变p53、Mdm2、p14和p21的表达及其相关性,探讨HCV核心蛋白对突变p53、Mdm2、p14和p21表达影响及临床意义。
2.
Studies have shown that the interaction between HCV core protein and the host cell plays an important role in liver steatosis.
有研究表明,HCV核心蛋白(HCV core)与宿主细胞相互作用在肝脂肪变中起重要作用。
5) Expression of HCV antigen
HCV抗原表达
6) Anti-HCV
抗-HCV
1.
A Follow-up Examination of Anti-HCV in Haemodialysis Patients Before and After Blood Transfusion;
血液透析患者输血前后抗-HCV的追踪检测
2.
Distribution and Epidemiological Trend of Anti-HCV among Free Blood Donors in Changsha city;
抗-HCV在无偿献血人群中的分布及流行趋势
3.
The core antigens of HCV and anti-HCV were tested by enzyme-linked immunosorbent assay(ELISA).
方法:采用荧光定量PCR法检测HCV-RNA、ELISA法同步检测抗-HCV和游离HCV核心抗原。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条